Mithra Announces the Extension of the Capital Commitment Agreement with LDA Capital by Two Years and the Increase of the Commitment by EUR 25 million

Liege, Belgium, 18 April 2022 – 7:30 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (“Mithra” or the “Company”), a company dedicated to Women’s Health, today announces the extension of the capital commitment agreement with LDA Capital Limited (“LDA Capital“) for a period of two additional years, as well as the increase of the commitment amount by EUR 25 million.